117 related articles for article (PubMed ID: 8549349)
1. Pharmacokinetic study of a new quinolone, DW-116.
Lee DK
Drugs; 1995; 49 Suppl 2():323-5. PubMed ID: 8549349
[No Abstract] [Full Text] [Related]
2. [Grepafloxacin (Raxar)].
Friis HM
Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
[No Abstract] [Full Text] [Related]
3. Grepafloxacin--a new fluoroquinolone.
Med Lett Drugs Ther; 1998 Jan; 40(1019):17-8. PubMed ID: 9465856
[No Abstract] [Full Text] [Related]
4. Prulifloxacin. NAD-441A, NM 441, Quisnon.
Drugs R D; 2002; 3(6):426-30. PubMed ID: 12516950
[No Abstract] [Full Text] [Related]
5. Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology.
Matsuda S
Drugs; 1995; 49 Suppl 2():395-8. PubMed ID: 8549375
[No Abstract] [Full Text] [Related]
6. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
[No Abstract] [Full Text] [Related]
7. Initial clinical experience with clinafloxacin in the treatment of serious infections.
Tack KJ; McGuire NM; Eiseman IA
Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411
[No Abstract] [Full Text] [Related]
8. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
10. Transplacental pharmacokinetics of the new fluoroquinolone DW-116 in pregnant rats.
Kim JC; Bae CS; Kim SH; Yun HI; Park SC; Shin HC; Han J; Chung MK
Toxicol Lett; 2003 Apr; 142(1-2):103-9. PubMed ID: 12765244
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats.
Yu IL; Chung SJ; Lee MH; Shim CK
J Pharm Sci; 1997 May; 86(5):550-3. PubMed ID: 9145377
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
Okuyama Y; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
[TBL] [Abstract][Full Text] [Related]
13. Penetration of NM441, a new quinolone, into human bile and gallbladder tissue.
Tanimura H; Ishimoto K; Murakami K; Uchiyama K; Iwakura S
Drugs; 1995; 49 Suppl 2():337-40. PubMed ID: 8549354
[No Abstract] [Full Text] [Related]
14. Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
Norrby SR
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():99-101. PubMed ID: 9484879
[No Abstract] [Full Text] [Related]
15. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
16. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of CFC-222 in animals.
Jung YH; Lee KS; Yeon KJ; Kim DH; Kim JH; Lee KH; Kim JW; Park KH
Drugs; 1995; 49 Suppl 2():321-2. PubMed ID: 8549348
[No Abstract] [Full Text] [Related]
18. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Wadworth AN; Goa KL
Drugs; 1991 Dec; 42(6):1018-60. PubMed ID: 1724637
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
[TBL] [Abstract][Full Text] [Related]
20. Effect of ferrous sulfate on the absorption of sparfloxacin in healthy volunteers and rats.
Kanemitsu K; Hori S; Yanagawa A; Shimada J
Drugs; 1995; 49 Suppl 2():352-6. PubMed ID: 8549359
[No Abstract] [Full Text] [Related]
[Next] [New Search]
